Volume 14 Issue 4
Jul.  2023
Turn off MathJax
Article Contents
Article Navigation >  ORGAN TRANSPLANTATION  > 2023  >  14(4): 619-622
Teng Fei, Song Shaohua, Fu Zhiren. Minutes of seminar on 2023 multi-center cooperation project of liver transplantation for metastatic liver cancer in China[J]. ORGAN TRANSPLANTATION, 2023, 14(4): 619-622. doi: 10.3969/j.issn.1674-7445.2023.04.021
Citation: Teng Fei, Song Shaohua, Fu Zhiren. Minutes of seminar on 2023 multi-center cooperation project of liver transplantation for metastatic liver cancer in China[J]. ORGAN TRANSPLANTATION, 2023, 14(4): 619-622. doi: 10.3969/j.issn.1674-7445.2023.04.021
shu

Minutes of seminar on 2023 multi-center cooperation project of liver transplantation for metastatic liver cancer in China

doi: 10.3969/j.issn.1674-7445.2023.04.021

  • Department of Organ Transplantation and Liver Surgery, the Second Affiliated Hospital of Naval Medical University, Shanghai 200003, China

More Information
  • Corresponding author: Fu Zhiren, Email: zhirenf@vip.sina.com
  • Received Date: 2023-05-31
    Available Online: 2023-07-13
  • Publish Date: 2023-07-15
    Abstract
  • Led by Zheng Shusen, Academician of Chinese Academy of Engineering (CAE) from Zhejiang University, the first multi-center cooperation project of liver transplantation for metastatic liver cancer in China, gathering 28 liver transplantation centers nationwide, was launched in Shanghai. All participating experts conducted in-depth exchanges and discussions regarding four topics including inclusion criteria of liver transplantation for metastatic liver cancer, the risk assessment and prognostic evaluation of liver transplantation for metastatic liver cancer, perioperative medication of liver transplantation for metastatic liver cancer, and the implementation details of multi-center cooperation project. Questionnaires were distributed to reach consensus and pinpoint the directions, aiming to carry out high-quality and standardized clinical researches on liver transplantation for metastatic liver cancer in China.

     

    • FullText(HTML)
  • loading
    • References(10)
  • [1]
    DUELAND S, SYVERSVEEN T, SOLHEIM JM, et al. Survival following liver transplantation for patients with nonresectable liver-only colorectal metastases[J]. Ann Surg, 2020, 271(2): 212-218. DOI: 10.1097/SLA.0000000000003404.
    [2]
    HERNANDEZ-ALEJANDRO R, RUFFOLO LI, SASAKI K, et al. Recipient and donor outcomes after living-donor liver transplant for unresectable colorectal liver metastases[J]. JAMA Surg, 2022, 157(6): 524-530. DOI: 10.1001/jamasurg.2022.0300.
    [3]
    BONNEY GK, CHEW CA, LODGE P, et al. Liver transplantation for non-resectable colorectal liver metastases: the International Hepato-Pancreato-Biliary Association consensus guidelines[J]. Lancet Gastroenterol Hepatol, 2021, 6(11): 933-946. DOI: 10.1016/S2468-1253(21)00219-3.
    [4]
    中国医师协会外科医师分会, 中华医学会外科学分会胃肠外科学组, 中华医学会外科学分会结直肠外科学组, 等. 中国结直肠癌肝转移诊断和综合治疗指南(2023版)[J]. 中华消化外科杂志, 2023, 22(1): 1-28. DOI: 10.3760/cma.j.cn115610-20221228-00762.

    Branch of Surgeons of Chinese Medical Doctor Association, Gastrointestinal Surgery Group of Branch of Surgery of Chinese Medical Association, Colorectal Surgery Group of Branch of Surgery of Chinese Medical Association. Chinese guidelines for diagnosis and comprehensive treatment of colorectal liver metastases (2023 edition)[J]. Chin J Dig Surg, 2023, 22(1): 1-28. DOI: 10.3760/cma.j.cn115610-20221228-00762.
    [5]
    NGUYEN NT, HARRING TR, GOSS JA, et al. Neuroendocrine liver metastases and orthotopic liver transplantation: the US experience[J]. Int J Hepatol, 2011: 742890. DOI: 10.4061/2011/742890.
    [6]
    LE TREUT YP, GRÉGOIRE E, KLEMPNAUER J, et al. Liver transplantation for neuroendocrine tumors in Europeresults and trends in patient selection: a 213-case European Liver Transplant Registry study[J]. Ann Surg, 2013, 257(5): 807-815. DOI: 10.1097/SLA.0b013e31828ee17c.
    [7]
    SUNG H, FERLAY J, SIEGEL RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. DOI: 10.3322/caac.21660.
    [8]
    SPOSITO C, DROZ DIT BUSSET M, CITTERIO D, et al. The place of liver transplantation in the treatment of hepatic metastases from neuroendocrine tumors: pros and cons[J]. Rev Endocr Metab Disord, 2017, 18(4): 473-483. DOI: 10.1007/s11154-017-9439-7.
    [9]
    DUELAND S, GRUT H, SYVERSVEEN T, et al. Selection criteria related to long-term survival following liver transplantation for colorectal liver metastasis[J]. Am J Transplant, 2020, 20(2): 530-537. DOI: 10.1111/ajt.15682.
    [10]
    LUO Y, TENG F, FU H, et al. Immunotherapy in liver transplantation for hepatocellular carcinoma: pros and cons[J]. World J Gastrointest Oncol, 2022, 14(1): 163-180. DOI: 10.4251/wjgo.v14.i1.163.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(2)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (220) PDF downloads(35) Cited by()
    Proportional views
    Related

    WeChat Subscription Account

    Wechat Service Account

    Contact Us
    • Tel：020-38736410
    • Email: organtranspl@163.com
    • Address：The Third Affiliated Hospital of Sun Yat-sen University, No. 600, Tianhe Road, Tianhe District, Guangzhou
    • Editorial Office of Organ Transplantation  粤ICP备2021030844号
    Links

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return